Evan Brower

Director, CMC at Elusys Therapeutics, Inc.

Evan Brower is an experienced professional in the field of biotechnology and pharmaceuticals, currently serving as the Director of CMC at Elusys Therapeutics, Inc. Previously, Evan held positions at NextCure, Inc. as Director of Technology Transfer and Associate Director of Process Development. Additionally, Evan worked at Catalent Pharma Solutions, advancing from Senior Manager of Manufacturing Sciences & Technology to Manager and Senior Scientist, while also serving as a Supervisor and Principal Investigator. Early in Evan's career, experience was gained at Johns Hopkins School of Medicine as a Postdoctoral Fellow and at Johns Hopkins University as a Graduate Research Assistant. Evan earned a Ph.D. in Biology from The Johns Hopkins University and a BS in Microbiology from the University of Illinois Urbana-Champaign.

Location

Woodstock, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Elusys Therapeutics, Inc.

Elusys Therapeutics is dedicated to delivering innovative medical countermeasures that enable fast, effective, and durable protection against infectious agents. Our goal is to accelerate the development and commercialization of novel biodefense solutions, such as our anthrax antitoxin ANTHIM® (obiltoxaximab), for strategic government partners.


Employees

11-50

Links